Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
36 studies found for:    "von Willebrand disease"
Show Display Options
RSS Create an RSS feed from your search for:
"von Willebrand disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
IL-11 in Adults With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
2 Completed Phase II Study of IL-11 (Neumega) in Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: recombinant interleukin-11
3 Completed
Has Results
IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
4 Completed National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
Condition: Von Willebrand Disease
Intervention:
5 Completed Study of Biostate® in Children With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate
6 Completed Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate®
7 Terminated A Study With OPTIVATE® in People With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
8 Recruiting Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
Conditions: Hemophilia A;   Hemophilia B;   Von Willebrand's Disease
Intervention:
9 Completed Extension Study of Biostate in Subjects With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Biological: Biostate
10 Completed Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery
Conditions: Acquired Von Willebrand Disease Secondary to Severe Aortic Stenosis;   Heye´s Syndrome;   Severe Aortic Stenosis
Intervention: Drug: desmopressin
11 Withdrawn A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B
Condition: Von Willebrand Disease
Intervention: Drug: ARC1779
12 Completed Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Condition: Von Willebrand Disease
Interventions: Biological: Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII);   Biological: Marketed plasma-derived VWF/FVIII concentrate
13 Completed Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador
Conditions: Von Willebrand Disease;   Hemophilia A;   Hemophilia B
Intervention:
14 Withdrawn Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)
Condition: Von Willebrand Disease
Intervention:
15 Recruiting Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
Condition: Von Willebrand Disease
Intervention: Other: Patients using wilate as standard of care
16 Terminated Optivate in People With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Optivate
17 Not yet recruiting Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Biological: Recombinant von Willebrand Factor (rVWF)
18 Completed A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.
Condition: vonWillebrand's Disease
Interventions: Biological: Optivate® (Human Coagulation Factor VIII);   Biological: Haemate P® (Human Coagulation Factor VIII)
19 Completed Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
Conditions: Von Willebrand Disease;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hematologic Disease
Intervention: Drug: Blood coagulation Factor VIII and vWF, human
20 Completed Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
Condition: Von Willebrand Disease
Intervention: Biological: Recombinant von Willebrand factor (rVWF) with or without rFVIII (Advate)

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Indicates status has not been verified in more than two years